Over the coming weeks, we’re spotlighting some of our design projects from the past few years. This week we’re looking back at OrisDX: A biotech company that is changing the way we screen for oral cancer. Founded in research from the University of Chicago, OrisDX has created a novel diagnostic saliva test that screens for oral cavity squamous cell carcinoma—the most common head and neck cancer. The screening is less invasive and more accurate than others in the category, allowing those at higher risk to test more proactively.
Currently a B2B company, OrisDX has a goal of becoming DTC in the future.
When they first came to us, they were looking for a new brand to use in investor presentations, their website, and other promotional and storytelling materials as they continued to find investors. Although it was a fast-turn project, we were able to design a brand identity system that encompassed a logo, a brand toolkit, and application examples such as a website landing page, testing kit, presentation slides, and print layouts.
Want to learn more about how we work? Click the button below to see our case studies.
No posts
Comments
Nothing yet. Say the first thing.
Sign in to join the conversation.